REFERENCES
Giuliano A, Kirgan D, Guenther J, Morton D. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391–401.
Kern K. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. J Am Coll Surg 1999; 189: 539–45.
Kern K, Rosenberg R. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99-m sulfur colloid. J Am Coll Surg 2000; 191: 479–89.
Kern K. Lymphoscintigraphic anatomy of sentinel lymphatic channels after subareolar injection of technetium 99m sulfur colloid. J Am Coll Surg 2001; 193: 601–8.
Kern K. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid. J Am Coll Surg 2002; 195: 467–75.
McMasters K, Giuliano A, Ross M, et al. Sentinel-lymph-node biopsy for breast cancer–not yet the standard of care. N Engl J Med 1998; 339: 990–5.
Smith L, Cross M, Klimberg V. Subareolar injection is a better technique for sentinel lymph node biopsy. Amer J Surg 2001; 180: 434–8.
Klimberg V, Rubio I, Henry R, et al. Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg 1999; 229: 860–5.
Nos C, Fréneaux P, Louis-Sylvestre C, et al. Macroscopic quality control improves the reliability of blue dye-only sentinel lymph node biopsy in breast cancer. Ann Surg Oncol 2003; 10: 525–30.
McMasters K, Wong S, Martin R, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 2001; 233: 676–87.
Veronesi U. The Lynn Sage Memorial Lecture: new developments in breast cancer management. J Am Coll Surg 2001; 192: 761–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kern, K.A. Achieving the Lowest False-Negative Rate in Peritumoral Breast Lymphatic Mapping: The Oncologic Search for the Holy Grail. Ann Surg Oncol 10, 486–487 (2003). https://doi.org/10.1245/ASO.2003.04.006
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1245/ASO.2003.04.006